The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent

Published:2015-08 Issue: Volume:5 Page:422
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Scicinski Jan,Fisher George,Carter Corey,Cho-Phan Cheryl,Kunz Pamela,Ning Shoucheng,Knox Susan,Oronsky Bryan,Caroen Scott,Parker Christopher,Fanger Gary,Reid Tony

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application;Journal of Experimental & Clinical Cancer Research;2023-09-01

2. RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist;Frontiers in Oncology;2023-05-29

3. A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation;Drugs;2023-03-15

4. Metabolic reprogramming in colorectal cancer: regulatory networks and therapy;Cell & Bioscience;2023-02-08

5. The role of NLRP3 inflammasome in digestive system malignancy;Frontiers in Cell and Developmental Biology;2022-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP